BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epi...

Full description

Saved in:
Bibliographic Details
Main Authors DEVITA, Robert Joseph, FOCKEN, Thilo, JOHNSON, James Philip Jr, ZENOVA, Alla Yurevna, CHOWDHURY, Sultan, GRIMWOOD, Michael Edward, ANDREZ, Jean-Christophe, COHEN, Charles Jay, HASAN, Syed Abid, DEHNHARDT, Christoph Martin, BURFORD, Kristen Nicole, EMPFIELD, James Roy
Format Patent
LanguageEnglish
French
German
Published 27.03.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
Bibliography:Application Number: EP20170726487